Supplementary Figures S1-S5, Tables S1-S3 from Survival Outcome and EMT Suppression Mediated by a Lectin Domain Interaction of Endo180 and CD147

Abstract

<p>Supplementary Figures S1-S5, Tables S1-S3. Figure S1. Silencing Endo180 disrupts normal and benign PEC acini, but not PTC spheroids. Figure S2. None of the treatment used in culture affected cell cycle and/or cell viability. Figure S3. Epitope mapping of the Mouse monoclonal anti-Endo180 39.10. Figure S4. Targeted blockade of Endo180 does not alter spheroid formation by PTCs. Figure S5. Highly glycosylated CD147 can be precipitated from normal PEC lysates using CTLD4 as bait. Supplementary Table S1. Antibodies and reagents used for Immunoblotting, Immunofluorescence and Immunohistochemistry. Supplementary Table S2. NCLPC1/4 prostate cancer tissue microarray patient characteristics, N = 157. Supplementary Table S3. NCLPC1/4 prostate cancer tissue microarray - patient deaths [censored] after three, five, seven and ten years.</p>